Upgrade to SI Premium - Free Trial

Larimar Therapeutics (LRMR)

4.02 0.00 (0.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 Larimar Therapeutics, For: Jul 06 Filed by: Hamilton Thomas Edward July 8, 2026 4:05 PM - SEC Filing Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens July 7, 2026 5:21 AM - StreetInsider H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy July 2, 2026 6:05 AM - StreetInsider Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird June 30, 2026 6:54 AM - StreetInsider Form 8-K Larimar Therapeutics, For: Jun 29 June 29, 2026 6:34 AM - SEC Filing Larimar files first BLA module for Friedreich's ataxia drug June 29, 2026 6:30 AM - StreetInsider Larimar Therapeutics Reports Positive Open Label Data and Submission of First Module of Rolling BLA for Accelerated Approval of Nomlabofusp for Friedreich’s Ataxia June 29, 2026 6:30 AM - Globe NewsWire Larimar Therapeutics to host investor event on June 29 June 26, 2026 4:05 PM - StreetInsider Larimar Therapeutics Announces Investor Event on the Nomlabofusp Program for Friedreich’s Ataxia June 26, 2026 4:05 PM - Globe NewsWire JPMorgan Starts Larimar Therapeutics (LRMR) at Overweight May 27, 2026 1:09 AM - StreetInsider Form 4 Larimar Therapeutics, For: May 19 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. May 20, 2026 8:03 PM - SEC Filing Form 4 Larimar Therapeutics, For: May 19 Filed by: LEFF JONATHAN S May 20, 2026 6:04 PM - SEC Filing Form 4 Larimar Therapeutics, For: May 19 Filed by: SHERMAN JEFFREY W May 20, 2026 4:31 PM - SEC Filing Form 4 Larimar Therapeutics, For: May 19 Filed by: Truitt Joseph May 20, 2026 4:28 PM - SEC Filing Form 4 Larimar Therapeutics, For: May 19 Filed by: THOMAS FRANK E May 20, 2026 4:25 PM - SEC Filing Form 4 Larimar Therapeutics, For: May 19 Filed by: Hamilton Thomas Edward May 20, 2026 4:22 PM - SEC Filing Form 8-K Larimar Therapeutics, For: May 19 May 19, 2026 4:28 PM - SEC Filing Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens May 15, 2026 5:03 AM - StreetInsider Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: Blue Owl Capital Holdings LP May 14, 2026 4:24 PM - SEC Filing Form 10-Q Larimar Therapeutics, For: Mar 31 May 14, 2026 4:19 PM - SEC Filing Larimar Therapeutics, Inc. (LRMR) Tops Q1 EPS by 22c May 14, 2026 7:34 AM - StreetInsider Form 8-K Larimar Therapeutics, For: May 14 May 14, 2026 7:03 AM - SEC Filing Larimar Therapeutics Reports First Quarter 2026 Financial and Business Update May 14, 2026 7:01 AM - Globe NewsWire Form SCHEDULE 13G/A Larimar Therapeutics, Filed by: MILLENNIUM MANAGEMENT LLC April 30, 2026 6:17 PM - SEC Filing Larimar Therapeutics Publishes Cross-Species Findings Supporting Skin as a Surrogate for the Measurement of Frataxin in Tissues Clinically Relevant to Friedreich’s Ataxia April 30, 2026 4:05 PM - Globe NewsWire Full Article List